PhRMA Statement on New Strategic Plan from the IP Enforcement Coordinator
WASHINGTON, D.C. (June 19, 2013) – Pharmaceutical Research and Manufacturers of America International Senior Vice President Rod Hunter issued the following statement today on the release of the second Joint Strategic Plan from the Intellectual Property Enforcement Coordinator (IPEC) Victoria Espinel:
New Coalition Seeks to Level the Playing Field for U.S. Businesses Competing in India
06.18.13 | By
A new alliance was launched today to begin educating the public and policymakers about the growing imbalance with the United States’ trading relationship with India and the potential consequences for American job losses if these concerns are not addressed.
PhRMA Joins with National Minority Quality Forum and Microsoft to Address Diversity in Clinical Trials
WASHINGTON, D.C. (June 18, 2013) – The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that it is partnering with the National Minority Quality Forum (NMQF) and Microsoft to help increase diversity in clinical trials.
PhRMA Statement on Supreme Court Ruling in Patent Settlement Case
WASHINGTON, D.C. (June 17, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President and General Counsel Mit Spears issued the following statement on the decision issued today by the U.S. Supreme Court in the case of Federal Trade Commission v. Actavis, Inc.:
Last week, we took another step in our fight against chronic disease by extending our successful partnership with the Women in Government Foundation, Inc. (WIG), a national non-profit, non-partisan organization of women state legislators.
The first step toward finding solutions in our health care ecosystem is to identify what works, protect what is successful and fix what isn’t. This includes access to medicines, continued research and development and developing programs that get patients the treatments they need.